MicroRNA and cancer--a brief overview.
暂无分享,去创建一个
Mario Acunzo | Giulia Romano | C. Croce | M. Acunzo | G. Romano | D. Wernicke | Carlo M Croce | Dorothee Wernicke
[1] J. Mendell,et al. MicroRNAs in cell proliferation, cell death, and tumorigenesis , 2006, British Journal of Cancer.
[2] C. Croce. Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.
[3] Peter S Linsley,et al. MicroRNAs and Cell Cycle Regulation , 2007, Cell cycle.
[4] A. Lund,et al. MicroRNA and cancer , 2012, Molecular oncology.
[5] A. Yee,et al. Correction: Versican G3 Domain Modulates Breast Cancer Cell Apoptosis: A Mechanism for Breast Cancer Cell Response to Chemotherapy and EGFR Therapy , 2012, PLoS ONE.
[6] A. Bradley,et al. Identification of mammalian microRNA host genes and transcription units. , 2004, Genome research.
[7] Zhiguo Wang. The guideline of the design and validation of MiRNA mimics. , 2011, Methods in molecular biology.
[8] Bin Li,et al. A miR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancer , 2013, OncoTargets and therapy.
[9] K. Vickers,et al. MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.
[10] M. Jovanović,et al. miRNAs and apoptosis: RNAs to die for , 2006, Oncogene.
[11] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] Mei Mei,et al. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status , 2010, Laboratory Investigation.
[13] S. Tavazoie,et al. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells , 2011, Nature.
[14] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[15] Xiaolan Zhu,et al. miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. , 2012, Acta Biochimica et Biophysica Sinica.
[16] P. Pandolfi,et al. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. , 2011, Cancer cell.
[17] G. Ruvkun,et al. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans , 1993, Cell.
[18] Sanghyuk Lee,et al. MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.
[19] M. Manzanares,et al. MiRNA-mediated regulation of cell signaling and homeostasis in the early mouse embryo , 2011, Cell cycle.
[20] Wei Wang,et al. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. , 2007, Cancer research.
[21] N. Rajewsky,et al. A pancreatic islet-specific microRNA regulates insulin secretion , 2004, Nature.
[22] F. Slack,et al. microRNA Control of Lifespan and Metabolism , 2006, Cell cycle.
[23] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[24] F. Slack,et al. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma , 2010, Nature.
[25] M. Esteller. Epigenetics in cancer. , 2008, The New England journal of medicine.
[26] C. Croce,et al. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis , 2013, Proceedings of the National Academy of Sciences.
[27] C. Croce,et al. Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2 , 2013, Proceedings of the National Academy of Sciences.
[28] C. Croce,et al. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation , 2012, Proceedings of the National Academy of Sciences.
[29] T. Tuschl,et al. Identification of Novel Genes Coding for Small Expressed RNAs , 2001, Science.
[30] Xiuping Liu,et al. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. , 2008, Biochemical pharmacology.
[31] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[32] G. Calin,et al. Clinical relevance of circulating cell-free microRNAs in cancer , 2014, Nature Reviews Clinical Oncology.
[33] George A Calin,et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.
[34] R. Hassan,et al. miRNA-451: A putative predictor marker of Imatinib therapy response in chronic myeloid leukemia. , 2012, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.
[35] M. Peter. Regulating cancer stem cells the miR way. , 2010, Cell Stem Cell.
[36] Nahum Sonenberg,et al. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC , 2012, Nature Structural &Molecular Biology.
[37] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[38] Ali Nahvi,et al. A Parsimonious Model for Gene Regulation by miRNAs , 2011, Science.
[39] Johan Hansson,et al. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. , 2010, The Journal of investigative dermatology.
[40] H. Ishii,et al. Role of microRNAs in solid tumors , 2011 .
[41] L. Lim,et al. An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans , 2001, Science.
[42] V. Kim,et al. The Drosha-DGCR8 complex in primary microRNA processing. , 2004, Genes & development.
[43] Woonyoung Choi,et al. miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy , 2009, Clinical Cancer Research.
[44] Jan-Fang Cheng,et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. , 2008, The New England journal of medicine.
[45] A. Bader,et al. Developing therapeutic microRNAs for cancer , 2011, Gene Therapy.
[46] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[47] Ugo Boggi,et al. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. , 2010, Cancer research.
[48] C. Croce,et al. microRNA involvement in human cancer. , 2012, Carcinogenesis.
[49] D. Kwong,et al. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. , 2013, Carcinogenesis.
[50] C. Croce,et al. MicroRNAs in Cancer. , 2009, Annual review of medicine.
[51] M. Stoffel,et al. Specificity, duplex degradation and subcellular localization of antagomirs , 2007, Nucleic acids research.
[52] Xiaohua Li,et al. Survival prediction of gastric cancer by a seven-microRNA signature , 2009, Gut.
[53] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[54] Michael F. Clarke,et al. Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.
[55] D. Brown,et al. The promise of microRNA replacement therapy. , 2010, Cancer research.
[56] V. Kim,et al. MicroRNA precursors in motion: exportin-5 mediates their nuclear export. , 2004, Trends in cell biology.
[57] V. Kim,et al. Biogenesis of small RNAs in animals , 2009, Nature Reviews Molecular Cell Biology.
[58] Jesse D. Ziebarth,et al. Treatment- and Population-Dependent Activity Patterns of Behavioral and Expression QTLs , 2012, PloS one.
[59] E. Kroh,et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.
[60] C. Morrison,et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.
[61] A. Tijsen,et al. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? , 2012, Circulation research.
[62] Jianli Lu,et al. Folding zones inside the ribosomal exit tunnel , 2005, Nature Structural &Molecular Biology.
[63] Sidhartha Hazari,et al. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. , 2012, The American journal of pathology.
[64] X. Yao,et al. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells , 2010, Acta Pharmacologica Sinica.
[65] S. Alahari,et al. miRNA control of tumor cell invasion and metastasis , 2010, International journal of cancer.
[66] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[67] S. Dimmeler,et al. MicroRNAs and Stem Cells: Control of Pluripotency, Reprogramming, and Lineage Commitment , 2012, Circulation research.
[68] C. Denkert,et al. An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity. , 2010, Cancer research.
[69] Burton B. Yang,et al. Stress Response of Glioblastoma Cells Mediated by miR-17-5p Targeting PTEN and the Passenger Strand miR-17-3p Targeting MDM2 , 2012, Oncotarget.
[70] P. Jin,et al. RNA and microRNAs in fragile X mental retardation , 2004, Nature Cell Biology.
[71] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[72] Hansjuerg Alder,et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. , 2009, Cancer cell.
[73] B. Harfe,et al. MicroRNAs in vertebrate development. , 2005, Current opinion in genetics & development.
[74] Peter A. Jones,et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.
[75] Cicek Gercel-Taylor,et al. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.
[76] F. Slack,et al. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. , 2008, Cancer research.
[77] Stefano Volinia,et al. MicroRNA Profiles Discriminate among Colon Cancer Metastasis , 2014, PloS one.
[78] B. Reinhart,et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.
[79] Í. Lopes-Cendes,et al. The new world of RNAs , 2013, Genetics and molecular biology.
[80] C. Croce,et al. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222 , 2012, Oncogene.
[81] Hyunsuk Shim,et al. Regulation of miR-19 to Breast Cancer Chemoresistance Through Targeting PTEN , 2011, Pharmaceutical Research.
[82] V. Ambros,et al. An Extensive Class of Small RNAs in Caenorhabditis elegans , 2001, Science.
[83] H. Xia,et al. MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[84] M. Fabbri,et al. Epigenetic regulation of miRNAs in cancer. , 2013, Advances in experimental medicine and biology.
[85] R. Shiekhattar,et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing , 2005, Nature.
[86] S. Tavazoie,et al. Control of metastatic progression by microRNA regulatory networks , 2013, Nature Cell Biology.
[87] R. Aharonov,et al. MicroRNAs accurately identify cancer tissue origin , 2008, Nature Biotechnology.
[88] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[89] Douglas D. Taylor,et al. Exosomal microRNA: a diagnostic marker for lung cancer. , 2008, Clinical lung cancer.
[90] D. Haber,et al. Dual Role for Argonautes in MicroRNA Processing and Posttranscriptional Regulation of MicroRNA Expression , 2007, Cell.
[91] Li Zhou,et al. Small RNAs have a large impact , 2012, RNA biology.
[92] Dennis Shasha,et al. miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAs , 2014, Nucleic acids research.
[93] A. Schetter,et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers , 2009, Proceedings of the National Academy of Sciences.
[94] J Ma,et al. MicroRNA and drug resistance , 2010, Cancer Gene Therapy.
[95] Oscar F. Silvestre,et al. A nanoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and in vivo , 2014, Nature Protocols.
[96] M. Hristov,et al. Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection , 2009, Science Signaling.